Key result
Sevoflurane anesthesia induced a rare but potentially lethal episode of torsade de pointes ventricular tachycardia and ventricular fibrillation in a 65-year-old woman.
Case Report (n=1)
Sevoflurane anesthesia may be a rare trigger for potentially lethal torsade de pointes ventricular tachycardia and ventricular fibrillation, even in patients with a normal baseline Q-T interval.
Answers are grounded in this paper and cite their sources.
Sevoflurane may rarely trigger TdP/VF even with normal QT; single case leaves open causality and need for confirmation.
The mechanism of torsade de pointes ventricular tachycardia (VT) is not fully understood. We present one case of a rare but potentially lethal arrhythmia induced by sevoflurane anesthesia. In our case, torsade de pointes VT changed to ventricular fibrillation (VF), but cardiac rhythm returned to atrial fibrillation after discontinuation of sevoflurane inhalation and returned to sinus rhythm at 12:00 AM on the first operative day. The mechanism, causes, and therapy of torsade de pointes VT are reviewed briefly. Case Report A 65-yr-old woman was scheduled for sigmoid resection for sigmoid cancer. She appeared wasted, with a weight loss of 6 kg over 3 mo, an arterial blood pressure of 140/80 mm Hg, and a heart rate of 90 bpm. Blood chemistry values were within normal limits. The electrocardiogram (ECG) showed a normal Q-T interval. Premedication consisted of atropine 0.5 mg and hydroxyzine 50 mg IM. Anesthesia was induced with thiopental 4 mg/kg and vecuronium 8 mg IV. Tracheal intubation was attempted three times. During tracheal intubation, the cardiac rhythm changed from sinus rhythm to atrial fibrillation. Disopyramide 100 mg was administered IV, but the atrial fibrillation was refractory to antiarrhythmic drugs. Anesthesia was maintained with N2 O/O2 50:50 and sevoflurane (end-expired concentration of 2%). Ten minutes after the induction of anesthesia, a brief period of VT was noticed (Figure 1, top trace). Blood pressure decreased to 60/40 mm Hg (Figure 1, second trace). IV lidocaine 150 bpm, frequent initiation by a premature ventricular beat occurring on a prolonged TU wave, and prolonged Q-T interval. The acquired type of torsade de pointes VT is more common than the congenital type. Schmeling et al. [5] have reported Q-T interval prolongation induced by halothane, isoflurane, and enflurane. There are no reports of sevoflurane-induced torsade de pointes VT. In our case, torsade de pointes VT occurred after the inhalation of sevoflurane and subsided after the sevoflurane effect had disappeared. The use of antiarrhythmic therapy depends on whether the Q-T interval is prolonged. Magnesium is used to manage supraventricular and ventricular tachyarrhythmias [6] and has been used successfully for therapy of torsade de pointes VT, even with normal serum magnesium levels [7]. In our case, however, magnesium was not effective for treating the VT. DC cardioversion is indicated with hemodynamic compromise, although arrhythmia tends to recur [3]. In our case, both VT and VF recurred after DC cardioversion. Previous reports have demonstrated prolongation of the Q-T interval in humans after thiopental and succinylcholine, sufentanil, or fentanyl administration [8,9]. Halothane and enflurane may prolong the Q-T interval in children [10]. In our case, general anesthesia was maintained by using sevoflurane, and the VT persisted and was refractory to antiarrhythmic drugs. After discontinuing sevoflurane inhalation, the cardiac rhythm returned to sinus rhythm. The etiology of sevoflurane for this arrhythmia could not be determined on the basis of this report. This polymorphic VT without prolonged Q-T interval may have been related to sevoflurane or N2 O. During the second surgery, we administered N2 O to maintain general anesthesia, but there were no episodes of arrhythmia during that surgery. Atrial fibrillation during tracheal intubation may have been a very important etiologic factor for polymorphic ventricular tachyarrhythmia in this case. In summary, we present one case of perianesthetic torsade de pointes VT that changed to VF during sevoflurane anesthesia.
No takes yet. Share an insight, caveat, or question.
Abe et al. (1998) conducted a case report in Torsade de pointes ventricular tachycardia and ventricular fibrillation (n=1). Sevoflurane was evaluated. Sevoflurane anesthesia induced a rare but potentially lethal episode of torsade de pointes ventricular tachycardia and ventricular fibrillation in a 65-year-old woman.
Synapse has enriched 10 related papers. Consider them for comparative context: